What This Document Is
This is a focused review of antibiotic medications, specifically designed for advanced pharmacology students (NR 508) at Chamberlain University. It serves as a primer on key antibiotic classes, their mechanisms of action, and common applications in treating infectious diseases. The document organizes antibiotics by their method of inhibiting bacterial cell wall synthesis, providing a structured overview of these critical medications.
Why This Document Matters
This review is essential for advanced practice nursing students preparing to prescribe and manage antibiotic therapies. It’s particularly valuable when needing a concise reference to quickly recall drug classifications, spectrums of activity, and important considerations for clinical decision-making. It’s intended for use during clinical rotations, exam preparation, and as a foundational resource for understanding antibiotic resistance patterns.
Common Limitations or Challenges
This document is a *review* and does not provide exhaustive coverage of all antibiotics or infectious disease treatment protocols. It focuses specifically on cell wall synthesis inhibitors and does not cover other antibiotic classes or detailed patient-specific dosing adjustments. It is not a substitute for comprehensive pharmacology textbooks or clinical guidelines.
What This Document Provides
The full “Revised Antibiotic Review (August 2019)” includes detailed information on:
* Beta-lactam antibiotics (Penicillins, Carbapenems, Monobactams, Cephalosporins) – including specific agents within each class.
* Glycopeptides (Vancomycin) – focusing on key pharmacokinetic/pharmacodynamic considerations.
* Mechanisms of resistance to these antibiotic classes, particularly regarding beta-lactamase production and PBP modification.
* Important clinical considerations for specific agents, such as ceftriaxone’s biliary excretion and imipenem’s seizure risk.
* Combinations of antibiotics with beta-lactamase inhibitors (Augmentin, Unasyn, Zosyn).
This preview *does not* include detailed dosing guidelines, coverage of all antibiotic classes, or specific treatment protocols for various infections. It also does not include information on newer combination therapies beyond those mentioned.
